Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Orelabrutinib
Locations
1
China
Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China
Start Date
July 1, 2023
Primary Completion Date
July 1, 2024
Completion Date
July 1, 2025
Last Updated
June 27, 2023
NCT06319456
NCT06476899
Lead Sponsor
Wang Xin
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions